Back to HRT Financial LP HRT Financial LP

SLXNSLXN

2 quarters

Position history for HRT Financial LPHRT Financial LP's holdings in Silexion Therapeutics Corp

No. HRT Financial exited its SLXN (Silexion Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 89,970 shares worth $47,000. HRT Financial first reported SLXN in Q3 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$47,000

Total Shares Change

-89,970

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q3
New
89,970
—
$47,0000.0%$8.70
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used